Table of Contents Chapter 1 Myasthenia Gravis Market Overview 1.1 Myasthenia Gravis Definition 1.2 Global Myasthenia Gravis Market Size Status and Outlook (2015-2030) 1.3 Global Myasthenia Gravis Market Size Comparison by Region (2015-2030) 1.4 Global Myasthenia Gravis Market Size Comparison by Type (2015-2030) 1.5 Global Myasthenia Gravis Market Size Comparison by Application (2015-2030) 1.6 Global Myasthenia Gravis Market Size Comparison by Sales Channel (2015-2030) 1.7 Myasthenia Gravis Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts on Current Market 1.7.5 Post-Strategies of COVID-19 Outbreak Chapter 2 Myasthenia Gravis Market Segment Analysis by Player 2.1 Global Myasthenia Gravis Sales and Market Share by Player (2018-2020) 2.2 Global Myasthenia Gravis Revenue and Market Share by Player (2018-2020) 2.3 Global Myasthenia Gravis Average Price by Player (2018-2020) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Myasthenia Gravis Market Segment Analysis by Type 3.1 Global Myasthenia Gravis Market by Type 3.1.1 Surgery 3.1.2 Medication 3.1.3 Plasmapheresis and Intravenous Immunoglobulin 3.1.4 Autologous Hematopoietic Stem Cell Transplantation 3.1.5 Other 3.2 Global Myasthenia Gravis Sales and Market Share by Type (2015-2020) 3.3 Global Myasthenia Gravis Revenue and Market Share by Type (2015-2020) 3.4 Global Myasthenia Gravis Average Price by Type (2015-2020) 3.5 Leading Players of Myasthenia Gravis by Type in 2020 3.6 Conclusion of Segment by Type Chapter 4 Myasthenia Gravis Market Segment Analysis by Application 4.1 Global Myasthenia Gravis Market by Application 4.1.1 Hospitals 4.1.2 Academic Research Institutes 4.1.3 Clinics 4.1.4 Other 4.2 Global Myasthenia Gravis Revenue and Market Share by Application (2015-2020) 4.3 Leading Consumers of Myasthenia Gravis by Application in 2020 4.4 Conclusion of Segment by Application Chapter 5 Myasthenia Gravis Market Segment Analysis by Sales Channel 5.1 Global Myasthenia Gravis Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Myasthenia Gravis Revenue and Market Share by Sales Channel (2015-2020) 5.3 Leading Distributors/Dealers of Myasthenia Gravis by Sales Channel in 2020 5.4 Conclusion of Segment by Sales Channel Chapter 6 Myasthenia Gravis Market Segment Analysis by Region 6.1 Global Myasthenia Gravis Market Size and CAGR by Region (2015-2030) 6.2 Global Myasthenia Gravis Sales and Market Share by Region (2015-2020) 6.3 Global Myasthenia Gravis Revenue and Market Share by Region (2015-2020) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Myasthenia Gravis Market Share by Type 6.4.3 North America Myasthenia Gravis Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Myasthenia Gravis Market Share by Type 6.5.3 Europe Myasthenia Gravis Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Myasthenia Gravis Market Share by Type 6.6.3 Asia-Pacific Myasthenia Gravis Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Myasthenia Gravis Market Share by Type 6.7.3 South America Myasthenia Gravis Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Myasthenia Gravis Market Share by Type 6.8.3 Middle East & Africa Myasthenia Gravis Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Myasthenia Gravis Players 7.1 AbbVie 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 COVID-19 Impact on AbbVie 7.2 Alexion Pharmaceuticals 7.3 Avadel Pharmaceuticals 7.4 Bausch Health 7.5 Baxter International 7.6 Biogen 7.7 Bristol-Myers Squibb 7.8 Catalyst Pharmaceuticals 7.9 Cipla 7.10 CSL 7.11 Curavac 7.12 Cytokinetics 7.13 Flamel Technologies 7.14 Fresenius Kabi 7.15 Galencia 7.16 GlaxoSmithKline 7.17 Grifols 7.18 Lupin Pharmaceuticals 7.19 Mitsubishi Tanabe Pharma 7.20 Novartis 7.21 Pfizer 7.22 Piramal Healthcare 7.23 Roche 7.24 RPG Life Sciences 7.25 Sun Pharmaceuticals 7.26 Takeda Pharmaceutical 7.27 Teva Pharmaceutical 7.28 Valeant Pharmaceuticals Chapter 8 Upstream and Downstream Analysis of Myasthenia Gravis 8.1 Industrial Chain of Myasthenia Gravis 8.2 Upstream of Myasthenia Gravis 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Myasthenia Gravis 8.3.1 Leading Distributors/Dealers of Myasthenia Gravis 8.3.2 Leading Consumers of Myasthenia Gravis Chapter 9 Development Trend of Myasthenia Gravis (2021-2030) 9.1 Global Myasthenia Gravis Market Size (Sales and Revenue) Forecast (2021-2030) 9.2 Global Myasthenia Gravis Market Size and CAGR Forecast by Region (2021-2030) 9.3 Global Myasthenia Gravis Market Size and CAGR Forecast by Type (2021-2030) 9.4 Global Myasthenia Gravis Market Size and CAGR Forecast by Application (2021-2030) 9.5 Global Myasthenia Gravis Market Size and CAGR Forecast by Sales Channel (2021-2030) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure Myasthenia Gravis Example Figure Global Myasthenia Gravis Revenue (Million $) Status and Outlook (2015-2030) Figure Global Myasthenia Gravis Revenue (Million $) Comparison by Region (2015-2030) Figure Global Myasthenia Gravis Revenue (Million $) Comparison by Type (2015-2030) Figure Global Myasthenia Gravis Revenue (Million $) Comparison by Application (2015-2030) Figure Global Myasthenia Gravis Revenue (Million $) Comparison by Sales Channel (2015-2030) Table Global Myasthenia Gravis Sales by Player (2018-2020) Table Global Myasthenia Gravis Sales Market Share by Player (2018-2020) Figure Global Myasthenia Gravis Sales Market Share by Player in 2020 Table Global Myasthenia Gravis Revenue (Million $) by Player (2018-2020) Table Global Myasthenia Gravis Revenue Market Share by Player (2018-2020) Figure Global Myasthenia Gravis Revenue Market Share by Player in 2020 Table Global Myasthenia Gravis Average Price by Player (2018-2020) Figure Global Myasthenia Gravis Average Price by Player in 2020 Figure Global Myasthenia Gravis Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018 Figure Global Myasthenia Gravis Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020 Figure Example of Surgery Figure Global Surgery Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Medication Figure Global Medication Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Plasmapheresis and Intravenous Immunoglobulin Figure Global Plasmapheresis and Intravenous Immunoglobulin Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Autologous Hematopoietic Stem Cell Transplantation Figure Global Autologous Hematopoietic Stem Cell Transplantation Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Other Figure Global Other Revenue (Million $) and Growth Rate (2015-2020) Table Global Myasthenia Gravis Sales by Type (2015-2020) Table Global Myasthenia Gravis Sales Market Share by Type (2015-2020) Figure Global Myasthenia Gravis Sales Market Share by Type in 2020 Table Global Myasthenia Gravis Revenue (Million $) by Type (2015-2020) Table Global Myasthenia Gravis Revenue Market Share by Type (2015-2020) Figure Global Myasthenia Gravis Revenue Market Share by Type in 2020 Table Global Myasthenia Gravis Average Price by Type (2015-2020) Figure Global Myasthenia Gravis Average Price by Type in 2020 Table Leading Players of Myasthenia Gravis by Type in 2020 Figure Example of Hospitals Figure Global Myasthenia Gravis for Hospitals Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Academic Research Institutes Figure Global Myasthenia Gravis for Academic Research Institutes Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Clinics Figure Global Myasthenia Gravis for Clinics Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Other Figure Global Myasthenia Gravis for Other Revenue (Million $) and Growth Rate (2015-2020) Table Global Myasthenia Gravis Sales by Application (2015-2020) Table Global Myasthenia Gravis Sales Market Share by Application (2015-2020) Figure Global Myasthenia Gravis Sales Market Share by Application in 2020 Table Leading Consumers of Myasthenia Gravis by Application in 2020 Figure Example of Direct Channel Figure Global Myasthenia Gravis for Direct Channel Revenue (Million $) and Growth Rate (2015-2020) Figure Example of Distribution Channel Figure Global Myasthenia Gravis for Distribution Channel Revenue (Million $) and Growth Rate (2015-2020) Table Global Myasthenia Gravis Revenue by Sales Channel (2015-2020) Table Global Myasthenia Gravis Revenue Market Share by Sales Channel (2015-2020) Figure Global Myasthenia Gravis Revenue Market Share by Sales Channel in 2020 Table Leading Distributors/Dealers of Myasthenia Gravis by Sales Channel in 2020 Table Global Myasthenia Gravis Market Size and CAGR by Region (2015-2030) Table Global Myasthenia Gravis Sales by Region (2015-2020) Table Global Myasthenia Gravis Sales Market Share by Region (2015-2020) Figure Global Myasthenia Gravis Sales Market Share by Region in 2020 Table Global Myasthenia Gravis Revenue (Million $) by Region (2015-2020) Table Global Myasthenia Gravis Revenue Market Share by Region (2015-2020) Figure Global Myasthenia Gravis Revenue Market Share by Region in 2020 Table North America Myasthenia Gravis Sales by Country (2015-2020) Figure North America Myasthenia Gravis Sales Market Share by Country (2015-2020) Table North America Myasthenia Gravis Revenue by Country (2015-2020) Figure North America Myasthenia Gravis Revenue Market Share by Country (2015-2020) Figure North America Myasthenia Gravis Market Share by Type in 2020 Figure North America Myasthenia Gravis Market Share by Application in 2020 Figure United States Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure United States Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Canada Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Canada Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Mexico Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Mexico Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Table Europe Myasthenia Gravis Sales by Country (2015-2020) Figure Europe Myasthenia Gravis Sales Market Share by Country (2015-2020) Table Europe Myasthenia Gravis Revenue by Country (2015-2020) Figure Europe Myasthenia Gravis Revenue Market Share by Country (2015-2020) Figure Europe Myasthenia Gravis Market Share by Type in 2020 Figure Europe Myasthenia Gravis Market Share by Application in 2020 Figure Germany Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Germany Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure UK Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure UK Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure France Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure France Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Italy Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Italy Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Russia Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Russia Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Spain Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Spain Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Table Asia-Pacific Myasthenia Gravis Sales by Country (2015-2020) Figure Asia-Pacific Myasthenia Gravis Sales Market Share by Country (2015-2020) Table Asia-Pacific Myasthenia Gravis Revenue by Country (2015-2020) Figure Asia-Pacific Myasthenia Gravis Revenue Market Share by Country (2015-2020) Figure Asia-Pacific Myasthenia Gravis Market Share by Type in 2020 Figure Asia-Pacific Myasthenia Gravis Market Share by Application in 2020 Figure China Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure China Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Japan Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Japan Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Korea Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Korea Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure India Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure India Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Southeast Asia Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Southeast Asia Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Australia Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Australia Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Table South America Myasthenia Gravis Sales by Country (2015-2020) Figure South America Myasthenia Gravis Sales Market Share by Country (2015-2020) Table South America Myasthenia Gravis Revenue by Country (2015-2020) Figure South America Myasthenia Gravis Revenue Market Share by Country (2015-2020) Figure South America Myasthenia Gravis Market Share by Type in 2020 Figure South America Myasthenia Gravis Market Share by Application in 2020 Figure Brazil Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Brazil Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Argentina Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Argentina Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Colombia Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Colombia Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Table Middle East & Africa Myasthenia Gravis Sales by Country (2015-2020) Figure Middle East & Africa Myasthenia Gravis Sales Market Share by Country (2015-2020) Table Middle East & Africa Myasthenia Gravis Revenue by Country (2015-2020) Figure Middle East & Africa Myasthenia Gravis Revenue Market Share by Country (2015-2020) Figure Middle East & Africa Myasthenia Gravis Market Share by Type in 2020 Figure Middle East & Africa Myasthenia Gravis Market Share by Application in 2020 Figure UAE Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure UAE Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure Saudi Arabia Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure Saudi Arabia Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Figure South Africa Myasthenia Gravis Sales and Growth Rate (2015-2020) Figure South Africa Myasthenia Gravis Revenue (Million $) and Growth Rate (2015-2020) Table Company Snapshot of AbbVie Table Myasthenia Gravis Introduction of AbbVie Table Myasthenia Gravis Sales, Price, Revenue, Gross Margin and Market Share of AbbVie (2018-2020) Table Industrial Chain of Myasthenia Gravis Table Manufacturing Cost Structure of Myasthenia Gravis Table General Manufacturing Process of Myasthenia Gravis Table Leading Distributors/Dealers of Myasthenia Gravis Table Leading Consumers of Myasthenia Gravis Figure Global Myasthenia Gravis Sales and Growth Rate Forecast (2021-2030) Figure Global Myasthenia Gravis Revenue and Growth Rate Forecast (2021-2030) Table Global Myasthenia Gravis Market Size and CAGR Forecast by Region (2021-2030) Table Global Myasthenia Gravis Market Size and CAGR Forecast by Type (2021-2030) Table Global Myasthenia Gravis Market Size and CAGR Forecast by Application (2021-2030) Table Global Myasthenia Gravis Market Size and CAGR Forecast by Sales Channel (2021-2030)

AbbVie Alexion Pharmaceuticals Avadel Pharmaceuticals Bausch Health Baxter International Biogen Bristol-Myers Squibb Catalyst Pharmaceuticals Cipla CSL Curavac Cytokinetics Flamel Technologies Fresenius Kabi Galencia GlaxoSmithKline Grifols Lupin Pharmaceuticals Mitsubishi Tanabe Pharma Novartis Pfizer Piramal Healthcare Roche RPG Life Sciences Sun Pharmaceuticals Takeda Pharmaceutical Teva Pharmaceutical Valeant Pharmaceuticals